Search
Now showing items 11-18 of 18
4,4’-dimethylaminorex (‘4,4’-DMAR’; ‘Serotoni’) misuse; a web-based study
(2017-06-28)
Background: 4,4′-DMAR (4,4’-dimethylaminorex; ‘Serotoni’) is a potent stimulant drug which has recently been associated with a number of fatalities in Europe. Over the last few years, online communities have emerged as ...
Intended and Unintended Use of Cathinone Mixtures
(2017-06-28)
Introduction: Cathinones are one of the most popular categories of new psychoactive substances (NPS) consumed. Cathinones have different pharmacological activities and receptor selectivity for monoamine transporters based ...
Can mobile phone technology support a rapid sharing of information on Novel Psychoactive Substances among health and other professionals internationally?
(2017-06-28)
Background The diffusion of Novel Psychoactive Substances (NPSs), combined with the ability of the Internet to act as an online marketplace, has led to unprecedented challenges for governments, health agencies, and substance ...
From concept(ion) to life after death/the grave: the ‘natural’ history and life-cycle(s) of Novel Psychoactive Substances (NPS)
(2017-06-28)
A range of information needs should be met in order to better understand and predict the longevity/existence of Novel Psychoactive Substances (NPS). This conceptual paper argues that one way of assessing how long a molecule ...
Is there a potential of misuse for Magnolia officinalis compounds/metabolites?
(2017-05-18)
Objective: Magnolia bark contains magnolol, metabolized to tetrahydromagnolol and honokiol, with both GABA-ergic/cannabimimetic activities, hence of possible attraction to vulnerable individuals/recreational misusers. ...
An international survey on the awareness, use, preference and health perception of Novel Psychoactive Substances (NPS)
(2017-05-08)
ObjectiveThis survey investigated the level of public awareness, preference and motivation of NPS use as well as knowledge of potential associated health risks.Methods A Bristol Online Survey was advertised through social ...
Novel psychoactive substance consumption is more represented in bipolar disorder than in psychotic disorders : A multicenter-observational study
(2017-05)
OBJECTIVE: Comorbidities between psychiatric diseases and use of traditional substances of abuse are common. Nevertheless, there are few data regarding the use of novel psychoactive substances (NPS) among psychiatric ...
Cannabis; epidemiological, neurobiological and psychopathological issues: an update
(2017-04-13)
Cannabis is the illicit drug with both the largest current levels of consumption and the highest reported lifetime prevalence levels in the world. Across different countries, the prevalence of cannabis use varies according ...